← Leaderboards
Frank J Palella
Northwestern University
$3,957,646
Attributed
$11,854,757
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4M · FY2023–25$5M$3.8M$2.5M$1.3M$0
'23
'24
'25
Funding mix
By agency
NIH$11,854,757 · 3
By mechanism
U01$11,845,666 · 1
M01$9,091 · 2
Top collaborators
- Valentina Stosor3 shared
- Steven M Wolinsky3 shared
Most similar at Northwestern University
Same institution · by research overlap
- Joseph T Bass$26,584,390
- Phyllis C Zee$19,629,845
- Steven M Wolinsky$81,032,362
- Boyd E Metzger$36,333,914
- Serdar E Bulun$27,655,930
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsClinical ResearchAdipose TissueAdvocacyAgingAgreementAntiaids AgentBiologyBasal MetabolismBasic ScienceBehaviorBig DataBiological FactorsBiological MarkersBiological ProcessAids TherapyBloodBlood SpecimenBody CompositionCatalogsCellsChronicClinical CareAdjudication
Grant awards (6)
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research$3,903,315
U01 · FY2025 · HL
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research$3,927,505
U01 · FY2024 · HL
Northwestern CORE Clinical Research Site: Trans-omics for HIV/AIDS Research$4,014,846
U01 · FY2023 · HL
Fat Maldistribution and Metabolic Changes in HIV-Infected Patients$9,091
M01 · FY2004 · RR
FAT MALDISTRIBUTION AND METABOLIC CHANGES IN HIV INFECTED PATIENTS$0
M01 · FY2001 · RR
FAT MALDISTRIBUTION AND METABOLIC CHANGES IN HIV INFECTED PATIENTS$0
M01 · FY2000 · RR